Malic Acid

Malic Acid

SCHEMBL7783136

Cl.O=C(O)CC(O)C(=O)O

nearest known ligand 0.94

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CACNA1CCACNA1DCACNA1FCACNA1SDRD2HTR1BHTR1DHTR1F

The experimentally established mechanism targets of Malic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.94
SLC22A6 Q4U2R8 1/20 0.53
TET2 Q6N021 6/20 0.52
TET3 O43151 2/20 0.52
TET1 Q8NFU7 1/20 0.52
KDM4A O75164 2/20 0.50
KDM4C Q9H3R0 2/20 0.50
KDM2A Q9Y2K7 2/20 0.50
OR51E2 Q9H255 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
GABRR1 P24046 2/20 0.43
LMNA P02545 1/20 0.43
KMO O15229 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Malic Acid SCHEMBL5365144 1.00 SMN1; SMN2 (0.94) SMN1; SMN2SLC22A6TET2TET3TET1
Malic Acid SCHEMBL9478094 0.97 SMN1; SMN2 (0.88) SMN1; SMN2SLC22A6TET2TET3TET1
Malic Acid SCHEMBL9478602 0.97 SMN1; SMN2 (0.88) SMN1; SMN2SLC22A6TET2TET3TET1
Malic Acid SCHEMBL6264226 0.97 SMN1; SMN2 (0.88) SMN1; SMN2SLC22A6TET2TET3TET1
Malic Acid SCHEMBL2179596 0.97 SMN1; SMN2 (0.88) SMN1; SMN2SLC22A6TET2TET3TET1
Malic Acid SCHEMBL89131 0.97 SMN1; SMN2 (1.00) SMN1; SMN2SLC22A6TET2TET3TET1
Malic Acid SCHEMBL14125844 0.97 SMN1; SMN2 (1.00) SMN1; SMN2SLC22A6TET2TET3TET1
Malic Acid SCHEMBL856 0.97
Malic Acid SCHEMBL256122 0.97
Malic Acid SCHEMBL98496 0.97

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4021663-A None JP disclosed
JP-6287140-A None JP disclosed
CN-119143744-A Oxadiazole compound, preparation method, pharmaceutical composition and application thereof 中国科学院上海药物研究所 2024-12-17 CN disclosed
CN-113861178-B Oxadiazole compound, preparation method, pharmaceutical composition and application thereof 中国科学院上海药物研究所 2024-09-13 CN disclosed
CN-117679563-B Preparation method of piezoelectric modified collagen sponge with porous structure 中国人民解放军总医院第四医学中心 2024-04-26 CN disclosed
CN-117679563-A Preparation method of piezoelectric modified collagen sponge with porous structure 中国人民解放军总医院第四医学中心 2024-03-12 CN disclosed
CN-115427038-A Methods of treating nervous system symptoms associated with lysosomal storage diseases 建新公司 2022-12-02 CN disclosed
CN-111407721-A A system for promoting penetration of active ingredients into skin 复旦大学 2020-07-14 CN disclosed
CN-106465785-A The removal methods of lead, cadmium in a kind of Semen phaseoli radiati albumen 南昌大学 2017-03-01 CN disclosed
CN-106417889-A Method for synchronously reducing contents of lead and cadmium in lotus seed protein 南昌大学 2017-02-22 CN disclosed
CN-106387619-A Method for synchronously reducing contents of lead and cadmium in pea protein through adsorption and substitution 南昌大学 2017-02-15 CN disclosed
CN-106387299-A Method for synchronously reducing contents of arsenic and copper in walnut protein 南昌大学 2017-02-15 CN disclosed
CN-106279351-A Arsenic, the method for copper content in simultaneous removing sunflower protein 南昌大学 2017-01-04 CN disclosed
CN-105925072-A Method for treating and modifying synthetic mica powder used for paint 江阴市友佳珠光云母有限公司 2016-09-07 CN disclosed
CN-105017281-A Salt of antofloxacin salt and preparation method and application thereof SHANGHAI INST MATERIA MEDICA 2015-11-04 CN disclosed
EP-0883342-B1 A COMPOSITION AND A METHOD FOR THE PROMOTION OF PLANT PRODUCTION AND/OR FOR THE ELIMINATION OF THE UNFAVOURABLE ENVIRONMENTAL INFLUENCES IN PLANT CULTIVATION BIOREX KUTATO FEJLESZTOE KFT (HU) 2001-10-10 EP disclosed
US-6268309-B1 HYDROXIMIC ACID DERIVATIVE Biorex Kutatóés FejlesztöRt. (HU) 2001-07-31 US disclosed
WO-1996039126-A2 RANITIDINE SALTS ON MAGNESIUM TRISILICATE AS AN ADSORBATE WARNER-LAMBERT COMPANY (US) 1996-12-12 WO disclosed
JP-H06287140-A ANGINAL THERAPEUTIC AGENT CONTAINING DILTIAZEM AND MOLSIDOMINE SYNTHELABO SA 1994-10-11 JP disclosed
JP-H0421663-A N-BENZYL-3-HYDROXYSUCCINAMIC ACID AND ITS PRODUCTION KANEGAFUCHI CHEM IND CO LTD 1992-01-24 JP disclosed